{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-072268","form_type":"8-K","ticker":"NDRA","cik":"0001681682","company_name":"ENDRA Life Sciences Inc.","filed_at":"2026-06-26T10:10:17+00:00","discovered_at":"2026-06-26T10:15:00.254809+00:00","generated_at":"2026-06-26T10:15:21.441378+00:00","sec_items":["1.01","5.01","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"ENDRA Life Sciences to merge with Noble Africa (Renergen), ASP Isotopes to control combined entity","bullets":["ENDRA enters merger with Noble Africa LLC; Merger Sub merges into Noble, with Noble surviving as ENDRA sub.","Concurrent $50M PIPE investment into Noble from ASPI and institutional investors at $6.57/unit.","Post-merger, ENDRA renamed Noble Africa Inc.; dual-class stock with Class B having 10 votes/share controlled by ASPI.","Board set at 7 directors: 5 Noble designees, 1 ENDRA designee, CEO; classified board.","Closing conditions include ENDRA having $3.8M cash, stockholder approval, SEC registration, and DFC consent."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-072268","json":"https://secwatch.observer/filing/0001213900-26-072268.json","markdown":"https://secwatch.observer/filing/0001213900-26-072268.md","text":"https://secwatch.observer/filing/0001213900-26-072268.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000121390026072268/0001213900-26-072268-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000121390026072268/ea0295239-8k425_endra.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T10:15:21.441378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}